ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CVSG Cvs Group Plc

1,066.00
6.00 (0.57%)
Last Updated: 08:40:12
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  6.00 0.57% 1,066.00 11,519 08:40:12
Bid Price Offer Price High Price Low Price Open Price
1,062.00 1,068.00 1,086.00 1,062.00 1,062.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 664.8M 6.2M 0.0864 122.69 760.42M
Last Trade Time Trade Type Trade Size Trade Price Currency
08:47:15 O 8 1,067.64 GBX

Cvs (CVSG) Latest News

Cvs (CVSG) Discussions and Chat

Cvs Forums and Chat

Date Time Title Posts
06/10/202418:28CVS Group: VETS,All things bright and beautiful965
07/10/201920:38Concerns founded?33

Add a New Thread

Cvs (CVSG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:47:161,067.64885.41O
07:45:451,063.4485903.93O
07:40:121,066.0040426.40AT
07:40:121,066.0023245.18AT
07:40:021,062.001121,189.44AT

Cvs (CVSG) Top Chat Posts

Top Posts
Posted at 07/10/2024 09:20 by Cvs Daily Update
Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 1,060p.
Cvs currently has 71,737,601 shares in issue. The market capitalisation of Cvs is £760,418,571.
Cvs has a price to earnings ratio (PE ratio) of 122.69.
This morning CVSG shares opened at 1,062p
Posted at 26/9/2024 08:20 by wad collector
Well that drop didn't last long ;about 15 minutes! Guess the lower numbers were all in the price.
Posted at 26/9/2024 07:56 by waldron
Latest Dividends

Summary Previous dividend Next dividend

Status Paid Declared

Type Final Final

Per share 7.5p 8p

Declaration date 21 Sep 2023 (Thu) 26 Sep 2024 (Thu)

Ex-div date 02 Nov 2023 (Thu) 31 Oct 2024 (Thu)

Pay date 08 Dec 2023 (Fri) 29 Nov 2024 (Fri)

DIVIDENDMAX
Posted at 20/9/2024 15:03 by 1jat
The truth is that the small local vets practices cannot cope with increasing investment required and management bandwidth to cover the full range of regulations vets have to comply with.
The young vets want a well paid job rather than being the business owner, so the old partners sell up to a corporate to realise their practice value because no one else will buy into it.
I think the CMA remedies will be about better price transparency to encourage shopping around….but the practicalities of getting pet medicine work against market pricing mechanisms except for routine pest control.
It is a bit like supermarkets, the CMA keeps going back but cant reach a definite solution, so the big players carefully tiptoe around the market creating an oligopoly and squeezing the smaller players out.
Posted at 24/5/2024 09:00 by roddyb
cvs share price seems to be holding up better than I expected, maybe a tenner-a-share is a bottom?
Posted at 15/5/2024 11:26 by roddyb
This sounds like an echo chamber. Advocating that the current vet fees are reasonable and there are no issues to answer - you ought to invest your life savings in CVS then? The reality is the public perception and the attraction of a Govt (either colour) jumping on the "cost of living battle" headlines. CVS is looking plummy for the CMA to bash around.

I remind you all that Dignity got trashed and never really recovered and was sucked off market at a cheap price as a result of the CMA
Posted at 05/4/2024 09:44 by roddyb
Roddyb is not a short because he has never understood how you actually open an account to short a share.

Roddyb was burnt (cremated) by Dignity when it faced the identical situation of being a duopoly investigated by CMA.

As a pet owner, I have not seen a British vet in years at CVS, the Brexit argument is not born out by my experiences. Whilst prices escalate the business is targeted by both Parties as being an easy win for headlines to counter the cost-of-living crisis that they are hoping the voters will judge them on.

Foreign vets are able to migrate to Britain as their services and CVS’s ability to organise visas saw off that problem.
Posted at 16/3/2024 12:05 by wallywoo
IVC Evidensia are the biggest player in the UK market with around 1000 UK locations (2500 worldwide). They are a private equity outfit, therefore, not mentioned in press. But are more then 5x the size of cvs (ww).


To me, the trend towards larger groups is all about economies of scale, not about exploiting a monopoly (most small vets have a near monopoly in their location anyway). I think it is likely any competition authority will come to the same conclusion. Making these practices cut their price will just close the smaller, less efficient vets and not help the market.


For those reasons I think this will recover over the next few months and have invested here yesterday at 1005. This share price drop could also attract a speculative bid imho. The USA are well ahead of UK, Europe, Australia with large vet groups. I am sure they will be looking at cvsg with interest now!! Huge companies such as Mars (already own 180 uk practices), Walmart etc are in this sector.
Posted at 16/3/2024 06:37 by lomax99
CVS discount is too high, says LiberumThe discount at which veterinary group CVS (CVSG) trades is 'too high', given the competition watchdog's review into vet practices is likely to prove there is no case to answer, says Liberum.Analyst Seb Jantet retained his 'buy' recommendation and target price of £22 on the stock, which gained 1.4% to £14.92 at the end of last week after its interim results. The shares have shed 21% over the year following the Competitions & Markets Authority (CMA) decision to investigate whether vets were providing consumers with value for money.Jantet said there was not a lot of new information in the result but added that 'we are still waiting for the most important piece of information, being the CMA's initial decision which is still expected in early 2024'.'While the shares have recovered a little over the last few months, they are still trading on undemanding multiples both in absolute terms and in relation to historic ratings, on a current year 2024 embedded value to pre-tax profit multiple of 9.9 times,' he said.'While we accept that the CMA uncertainty warrants a discount over the historic rating of around 15 times, the discount looks too high to us, especially given our view that there is a good chance the CMA will conclude there isn't a case to answer when it next updates.'
Posted at 13/3/2024 05:29 by undervaluedassets
Well we now have a 2017 share price

And in 2017 the company had EPS of 18p, profits of 14 million and a 271 million turnover.

Is that what we should expect? instead of the pencilled 80-90p in earnings on 50-90 million in profit on a turnover of 670 million?

I do not see that being the case...

Ergo .. cheap

The market panicked today. In the past, I have done well out of buying into panics.
Posted at 07/9/2023 11:40 by maywillow
Michele Maatouk
Sharecast News
07 Sep, 2023 09:35 07 Sep, 2023 09:41


Pets at Home, CVS tumble as CMA launches review of vet services


Shares of Pets at Home and CVS Group tumbled on Thursday after the Competition and Markets Authority said it was launching a probe into the £2bn veterinary services market for household pets.




The competition watchdog said it will explore how well the market is working for pet owners and whether they are receiving the information they need at the right time to get appropriate treatment for their pets.

The CMA said it was keen to hear more about pet owners’ and vet practitioners’ experiences of pricing of services, including whether pet owners were aware of how much a treatment would cost, and how they pay for it.

It also wants to hear about how prescriptions and medication for pets are arranged and sold and how pet owners choose a vet surgery - whether they are aware that their vet may be part of a larger chain which might also own other surgeries in the area.

The use of out-of-hours and emergency vet services where options might be limited will also be looked into.

CMA chief executive Sarah Cardell said: "Caring for an ill pet can create real financial pressure, particularly alongside other cost of living concerns. It’s really important that people get clear information and pricing to help them make the right choices.






"There has been a lot of consolidation in the vet industry in recent years, so now is the right time to take a look at how the market is working.

"When a pet is unwell, they often need urgent treatment, which means that pet owners may not shop around for the best deal, like they do with other services. This means they may not have the relevant information to make informed decisions at what can be a distressing time. We want to hear from pet owners and people who work in the sector about their experiences."

Pets at Home owns veterinary groups Companion Care Vets and Vets4Pets and has a network of more than 450 vet practices across the UK. CVS Group, meanwhile, is one of the largest integrated veterinary services providers in the UK.

At 0925 BST, Pets shares were down 11.2% at 336.20p. Shares of AIM-listed vet services provider CVS Group were down 29% at 1,479.00p.

Russ Mould, investment director at AJ Bell, said: "Being in the pets and vet space has felt like a healthy place to be in recent years. That’s been reflected in strong share prices for the likes of vet group CVS and Pets at Home which has its own veterinary arm within a broader retail and grooming offering.

"Britons love their animal companions and are willing to pay up to keep them healthy and happy.

"News that the competition authorities are looking into the rising costs and potentially anti-competitive practices in the industry has set the cat among the pigeons when it comes to the share prices of CVS and Pets at Home.

"The sell-off seen today could be an overreaction, although the CMA review looks to be wide-ranging. The problem for both businesses is the process is likely to be time-consuming and, with a further update not due until early 2024, it could weigh on both stocks for some time to come."
Cvs share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock